Dr. Reddy’s: Gilead Partnership Expands Global
Dr. Reddy’s Laboratories has expanded its collaboration with Gilead Sciences through a royalty-free, non-exclusive voluntary licence for investigational once-yearly lenacapavir, an HIV pre-exposure prophylaxis (PrEP) treatment. The agreemen…



















